Literature DB >> 18571043

Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

Luis Junquera1, Lorena Gallego.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571043     DOI: 10.1016/j.joms.2008.02.012

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  23 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

Review 2.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

3.  Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Authors:  N Ersan; L J van Ruijven; A L J J Bronckers; V Olgaç; D Ilgüy; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

Review 4.  Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review.

Authors:  Paul de Boissieu; L Kanagaratnam; R Mahmoudi; A Morel; M Dramé; T Trenque
Journal:  Eur J Clin Pharmacol       Date:  2017-02-10       Impact factor: 2.953

5.  In vitro bactericidal effect of Nd:YAG laser on Actinomyces israelii.

Authors:  Paolo Vescovi; Stefania Conti; Elisabetta Merigo; Tecla Ciociola; Luciano Polonelli; Maddalena Manfredi; Marco Meleti; Carlo Fornaini; Jean-Paul Rocca; S Amir Nammour
Journal:  Lasers Med Sci       Date:  2012-09-29       Impact factor: 3.161

6.  Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws.

Authors:  Akrivoula Soundia; Danny Hadaya; Sanjay M Mallya; Tara L Aghaloo; Sotirios Tetradis
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-08-29

7.  Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

Authors:  Vittorio Fusco; Alberto Bedogni; Alfredo Addeo; Giuseppina Campisi
Journal:  Support Care Cancer       Date:  2016-03-09       Impact factor: 3.603

Review 8.  Side effects of bone-targeted therapies in advanced breast cancer.

Authors:  Christoph Domschke; Florian Schuetz
Journal:  Breast Care (Basel)       Date:  2014-10       Impact factor: 2.860

9.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

10.  Bisphosphonates and osteonecrosis: an open matter.

Authors:  Paolo Vescovi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.